Ki Mun Kang

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

Seok Jin Kim, Byung‐Soo Kim, Chul Yong Kim et al. · Journal of Clinical Oncology · 2009 · 340 citations · Full text

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

Byung Ock Choi, Ihl Bohng Choi, Hong Seok Jang et al. · BMC Cancer · 2008 · 149 citations · Full text

Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic Complication

Seok Hyun Son, Byung Ock Choi, Mi Ryeong Ryu et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 138 citations

Stereotactic Body Radiotherapy, Surgical Oncology, Hepatology +12

A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1–2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study

Sung Ho Moon, Kwan Ho Cho, Eun Ji Chung et al. · Radiotherapy and Oncology · 2013 · 87 citations

Radiation Medicine, Radiation Therapy, Conventional Fractionation Radiotherapy +7

Fractionated Stereotactic Radiotherapy in Patients with Primary Hepatocellular Carcinoma

Byung Ock Choi, Hong Seok Jang, Ki Mun Kang et al. · Japanese Journal of Clinical Oncology · 2006 · 86 citations